Connect with us

Daily Report USA

CDC CONFESSED: PCR Can’t Make A Difference Between Flu And C-19!


CDC CONFESSED: PCR Can’t Make A Difference Between Flu And C-19!

The CDC asked for emergency use of the PCR test.

CDC shared: ‘’In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider the adoption of a multiplexed method that can facilitate the detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing.’’

They tell the doctors to use the tests that can tell the difference. People have to know this.

The CDC asked for emergency use in July, after December 31.

People commented on Twitter about this:


Everything is for money; they make the world goes round.

AACC reported:

Roche has earned Food and Drug Administration emergency use authorization for the cobas SARS-CoV-2 nucleic acid test for use on the cobas Liat system. According to Roche, this singleplex test is the first real-time reverse transcriptase-polymerase chain reaction test that identifies SARS-CoV-2 infection within 20 minutes, and that is authorized to screen both symptomatic and asymptomatic persons at the point of care. It also offers broad SARS-CoV-2 strain coverage as monitored by Roche’s ongoing variant surveillance program. The cobas Liat system fully automates the testing process and features a simplified workflow that enables healthcare professionals to perform this test with minimal training. The cobas SARS-CoV-2 nucleic acid test is intended for use at a wide range of point-of-care settings, including emergency and primary care settings, physician offices, and other SARS-CoV-2 screening locations. It is also available in markets accepting the CE mark.

This test is going to be as efficient as the last.

Content curated & edited from

Continue Reading
You may also like...
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

More in opinion

To Top